Isleworth Healthcare Acquisition priced its IPO of 18 million units at $10 each, representing an upsize for 3 million more units than expected.
Units begin trading today on the Nasdaq under ISLEU. Each consists of one share of common stock and one-half of a redeemable warrant. Each whole warrant is exercisable at $11.50. Once the securities comprising the units begin separate trading, stock and warrants are expected to list under ISLE and ISLEW, respectively.
The new SPAC plans to target companies in North America, Europe and Asia that are developing assets in the biopharmaceutical and medical technology/medical device space. Read more.
